SUDS3: A Potential Drug Target and Biomarker (G64426)

Target Name: SUDS3

NCBI ID: G64426

SUDS3

SUDS3: A Potential Drug Target and Biomarker

Introduction

SUDS3 (SDS3 homolog, SIN3A corepressor complex component) is a gene that has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. SUDS3 is a member of the SIN3A gene family, which is Known for its role in cell signaling pathways, including the regulation of ion channels and protein kinases. The SIN3A family has also been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The SUDS3 gene

SUDS3 is a gene that is located on chromosome 16 at position 247.2. It is a member of the SIN3A gene family, which is known for its role in the regulation of ion channels and protein kinases. The SIN3A gene has four splice variants, which are designated as SIN3A1, SIN3A2, SIN3A3, and SIN3A4. SIN3A1 is the most abundant splice variant, and it is expressed in most tissues and organs. SIN3A2 is the second most abundant splice variant, and it is expressed in the brain and other nervous tissue. SIN3A3 is the least abundant splice variant, and it is expressed in the heart and other cardiovascular tissue. SIN3A4 is the smallest splice variant, and it is expressed in the liver.

SUDS3 function

SUDS3 is a gene that is involved in the regulation of a variety of cellular processes, including cell signaling pathways, DNA replication, and protein synthesis. It is a member of the SIN3A gene family, which is known for its role in the regulation of ion channels and protein kinases. The SIN3A gene has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

One of the functions of SUDS3 is to regulate the activity of the ion channels that are involved in the regulation of intracellular signaling pathways. These channels include potassium ion channels (K+ channels), calcium ion channels (Ca2+ channels), and voltage-gated ion channels (VGICs). By regulating the activity of these channels, SUDS3 is involved in a variety of cellular processes, including the regulation of muscle and nerve function, the regulation of the contraction and relaxation of blood vessels, and the regulation of the formation of new blood vessels.

Another function of SUDS3 is to regulate the activity of the protein kinases that are involved in the regulation of cellular signaling pathways. These kinases include casein kinase (CK), serine/thionine protein kinase (STK), and c-JunN-terminal kinase ( JNK). By regulating the activity of these kinases, SUDS3 is involved in a variety of cellular processes, including the regulation of cell growth, differentiation, and apoptosis.

SUDS3 as a drug target

SUDS3 is a gene that is involved in the regulation of a variety of cellular processes, including cell signaling pathways, DNA replication, and protein synthesis. As a result, it is a potential drug target for a variety of diseases.

One of the potential benefits of targeting SUDS3 is that it is involved in the regulation of a variety of cellular processes that are important for human health and disease. For example, SUDS3 is involved in the regulation of ion channels and protein kinases, which are involved in the regulation of muscle and nerve function, the regulation of the contraction and relaxation of blood vessels, and the regulation of the formation of new blood vessels. Targeting SUDS3 could potentially lead to the development of new treatments for a variety of diseases, including cancer , neurodegenerative diseases, and metabolic disorders.

Another potential benefit of targeting SUDS3 is that it is a gene that has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders. By targeting SUDS3 with drugs

Protein Name: SDS3 Homolog, SIN3A Corepressor Complex Component

Functions: Regulatory protein which represses transcription and augments histone deacetylase activity of HDAC1. May have a potential role in tumor suppressor pathways through regulation of apoptosis. May function in the assembly and/or enzymatic activity of the mSin3A corepressor complex or in mediating interactions between the complex and other regulatory complexes

The "SUDS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUDS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets